PremiumCompany AnnouncementsPluri Announces Strategic Merger to Enhance Market Position Pluri Proposes Extension of Convertible Bond Maturity to Key Investor Pluri Inc. Faces Financial Challenges Amid Continued Innovation PremiumThe FlyPluri secures $6.5M investment, acquires 71% stake in Kokomodo for $4.5M Pluri congratulates Mesoblast, CEO on FDA approval of MSC-based therapy Pluri assesses readiness to mass produce PLX-R18 PremiumThe FlyPluri trading halted, volatility trading pause Pluri signs tech transfer, manufacturing agreement with Kadimastem Pluri announces proof of concept agreement with an agriculture corporation 
